Xianjun Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Cell Cycle Arrest

Pluripotent Stem Cells

Dna Damage Response

Top Venues

Metabolic brain disease

This page only lists publications with an associated author ORCID identifier.

Publications

Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)
Wang Chen, Pida Hao, Xiaotong Feng, Xiaotong Feng, Xuan Zhao, Jincheng Wu, Zixiang Gong, Jinli Zhang, Xiao-Yan Fu, Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis. Metabolic brain disease 39 (4) (2024)